首页 › 基金 › Venrock Adviser, LLC › ARTV
Venrock Adviser, LLC 对 ARTV 的持仓历史
ARTIVA BIOTHERAPEUTICS INC · 医疗保健
Venrock Adviser, LLC 在 Q3 2026 的 13F 申报中披露持有 ARTV(ARTIVA BIOTHERAPEUTICS INC)2,043,596 股,市值约 US$14.6M,约占其申报组合的 0.71%,在其申报持仓中市值排名第 29 位。 Venrock Adviser, LLC 最近 9 个申报季度中有 9 个季度披露了 ARTV 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Venrock Adviser, LLC 对 ARTV 的持仓演变
Venrock Adviser, LLC 于 Q3 2024 首次披露 ARTV 持仓:1,609,569 股(约 US$24.9M)。 在 9 次申报中,Venrock Adviser, LLC 1 次增持、0 次减持、7 次保持不变。 最近一期申报(Q3 2026)显示持股 2,043,596 股、市值约 US$14.6M。 持仓曾出现大幅变动:Q2 2026 增持约 27% (随后一个季度股价下跌 27%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 1.61M | $24.87M | 新进 |
| Q4 2024 | 1.61M | $16.22M | 持有 |
| Q1 2025 | 1.61M | $4.83M | 持有 |
| Q2 2025 | 1.61M | $2.43M | 持有 |
| Q3 2025 | 1.61M | $4.62M | 持有 |
| Q4 2025 | 1.61M | $6.91M | 持有 |
| Q1 2026 | 1.61M | $10.37M | 持有 |
| Q2 2026 | 2.04M | $19.82M | 增持 |
| Q3 2026 | 2.04M | $14.55M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ARTV 与 13F 数据
ARTV(ARTIVA BIOTHERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 87 只申报持有 ARTV,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$220.2M), 5AM Venture Management, LLC (US$139.1M), Deep Track Capital, LP (US$73.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ARTV 的基金
- RA CAPITAL MANAGEMENT, L.P. 23.79M 股 · $220.20M · Q3 2026
- 5AM Venture Management, LLC 9.68M 股 · $139.10M · Q3 2026
- Deep Track Capital, LP 4.41M 股 · $73.62M · Q3 2026
- Blue Owl Capital Holdings LP 4.13M 股 · $63.84M · Q3 2026
- Foresite Capital Management V, LLC 3.56M 股 · $59.50M · Q3 2026
- Foresite Capital Management VI LLC 2.20M 股 · $36.80M · Q3 2026
- Cormorant Asset Management, LP 1.82M 股 · $30.32M · Q3 2026
- ORBIMED ADVISORS LLC 1.68M 股 · $27.98M · Q3 2026
- Sanofi 672.78K 股 · $11.24M · Q3 2026
- Caligan Partners LP 1.48M 股 · $10.55M · Q3 2026
- Samsara BioCapital, LLC 954.86K 股 · $6.80M · Q3 2026
- Saturn V Capital Management LP 300.36K 股 · $5.02M · Q3 2026
更多关于 Venrock Adviser, LLC
常见问题
How long has Venrock Adviser, LLC held ARTV?
Venrock Adviser, LLC has disclosed ARTV holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Venrock Adviser, LLC's current position in ARTV?
As of Q3 2026, Venrock Adviser, LLC holds 2.04M shares of ARTV (ARTIVA BIOTHERAPEUTICS INC), valued at $14.55M, representing 0.71% of its reported portfolio and ranking #29.
Has Venrock Adviser, LLC been buying or selling ARTV?
In the latest 13F filing (Q3 2026), Venrock Adviser, LLC held unchanged its position in ARTV.
Which other funds hold ARTV?
Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Deep Track Capital, LP, among 87 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.